Subscribe
istock-680381152zapp2photo
Zapp2Photo / iStockphoto.com
14 November 2018Americas

IBM patent targets blockchain in open scientific research

Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot
17 June 2019   The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot
17 June 2019   The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.

More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot
17 June 2019   The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent